Mometasone Nasal Spray (Mometasone Furoate)
Mometasone Furoate 0.5mg
Suspension · Prescription medication
Genewon Science Co., Ltd.
MFDS item code 201900972 · Notified 2019.02.18 · Insurance code 671705931
Prevention and improvement of symptoms of allergic rhinitis (seasonal, perennial) and sinusitis, nasal polyps.
This medication is used to prevent or alleviate symptoms of seasonal and perennial allergic rhinitis in adults and children over 2 years of age. A preventive therapy that starts 2 to 4 weeks before pollen exposure is effective, especially for patients with moderate to severe allergic rhinitis. Additionally, it helps treat symptoms of nasal polyps in adults aged 18 and older. It is also used to relieve symptoms of acute rhinosinusitis without bacterial infection in adults and adolescents aged 12 and older. This medication assists in improving various symptoms related to rhinitis and sinusitis.
For allergic rhinitis: 2 sprays in each nostril once daily (total daily dose of 0.2 mg). If symptoms improve, the maintenance dose can be reduced to 1 spray in each nostril once daily (total daily dose of 0.1 mg). It is possible to increase the dosage to a maximum of 4 sprays in each nostril once daily (total daily dose of 0.4 mg). For nasal polyps: 2 sprays in each nostril once daily (total daily dose of 0.2 mg).
For allergic rhinitis: Children aged 2 to 11 years should use 1 spray in each nostril once daily (total daily dose of 0.1 mg).
This medication should not be used in patients with hypersensitivity to this drug or its components or a history of such reactions. It is also contraindicated in patients with untreated local infections of the nasal mucosa. If a patient has recently undergone nasal surgery or has lesions, ulcers, or trauma in the nasal area, this medication should not be used until the wounds are completely healed. Safety has not been established in infants under 2 years of age. Patients with respiratory tuberculosis, systemic infections, or herpes simplex in the eyes must use this medication cautiously. Patients prone to frequent nosebleeds should be cautious as bleeding may worsen. Patients at risk of varicella or measles infection should take precautions and seek medical attention if necessary. Its effects have not been adequately studied in patients with unilateral nasal polyps or cystic fibrosis, thus it should be used cautiously. Women who are pregnant or may become pregnant, as well as nursing mothers, should use this medication with caution according to a doctor’s advice. Side effects such as headache, nosebleeds, pharyngitis, cough, upper respiratory infections may occur during use. Occasionally, adverse reactions such as skin rashes, nasal mucosal irritation, liver function abnormalities, and blood count changes may occur, so consult a doctor if there are abnormal symptoms. Rarely, immediate allergic reactions such as bronchospasm or difficulty breathing can occur following nasal administration, so discontinue use immediately and seek treatment if symptoms appear. Prolonged use of high doses may lead to systemic corticosteroid side effects, so monitoring is necessary. If symptoms of nasal infections or nasal mucosal irritations persist, discontinue use and seek appropriate treatment. During long-term use, the condition of the nasal mucosa should be regularly checked for abnormalities, particularly if local fungal infections occur in the nose or pharynx, the use of this medication should be stopped and treated. This drug has a low potential to induce glaucoma or cataracts, but if there are changes in vision, an ophthalmologist should be consulted. No special treatment is needed for overdose, but like systemic corticosteroids, adrenal suppression may occur, so caution is necessary. Before use, shake the container well and perform a test spray to ensure an even spray, and avoid spraying directly into the eyes or septum; it should only be used for nasal administration. Keep out of reach of children, and pregnant or nursing women should use it with caution according to a doctor’s instructions. This medication may interact with other drugs, and especially when used in combination with CYP3A4 inhibitors, the risk of side effects may increase, thus caution is necessary. In children, there may be a risk of growth delay, so it is important to regularly monitor growth status and use the minimum effective dose. Elderly patients may have reduced physical function, so their condition should be monitored and used with caution.
Hives, severe swelling (angioedema), chest tightness, difficulty breathing, cold sweat, pallor, symptoms of anaphylaxis, severe rash with high fever, blisters, peeling skin, pain in oral/ocular mucosa, difficulty in breathing or shortness of breath, asthma attack, respiratory distress with cough and fever, jaundice (yellowing of skin or eyes), extreme fatigue throughout the body, sudden and severe headache, lightning-like headache, seizures, confusion.
Headache, viral infections, pharyngitis, nosebleeds/blood-stained mucus, cough, upper respiratory infections, menstrual disorders, musculoskeletal pain, sinusitis, vomiting, joint pain, asthma, bronchitis, chest pain, conjunctivitis, diarrhea, dyspepsia, otalgia, cold symptoms, myalgia, nausea, rhinitis, diarrhea, nasal inflammation, otitis media, wheezing, skin trauma, nasal symptoms (irritation, itching, dryness, pain, redness, discomfort, etc.), and positive fungal test result for nasal area.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 2 and 25 degrees Celsius in a cool, dry place.
An opaque suspension that is white or almost white, contained in a bottle that dispenses a certain amount per spray.
18mL/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Mometasone Furoate 0.5mg
Suspension · Prescription medication
Genewon Science Co., Ltd.
Mometasone Furoate Monohydrate 0.517mg
Suspension · Prescription medication
Korea Organon Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Korea Organon Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Donggu Bio Pharmaceutical Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Mometasone Furoate 1mg
Ointment · Prescription medication
Dongkwang Pharmaceutical Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Bionex Co., Ltd.
Mometasone Furoate 1mg
Cream · Prescription medication
Taegeuk Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.